UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Hanmi makes public 23 new drug pipelines on its website
Hanmi Pharm한미약품 (CEO Kwon Se-Chang권세창 and Woo Jong-soo우종수), announced 23 ne...
by Marian Chu
|
2017-04-10 18:04
라인
K-Pharma Academy promotes Korean-Latin American ties
The Korea Health Industry Development Institute (KHIDI) completed its annua...
by Constance Williams
|
2017-04-10 15:40
라인
Companies have to cooperate to develop ‘surgery robot’: KEIT
To target rapidly growing surgery robot market, domestic businesses need to...
by Nam Doo-hyun
|
2017-04-10 14:12
라인
Hanmi’s osteoporosis therapy combines Evista with vitamin D
Hanmi Pharm has released a complex drug by combining Evista (compound: Ralo...
by Lee Hye-seon
|
2017-04-10 11:59
라인
Korea’s healthcare educational material picked as manual for WHO’s West Pacific chapter
The educational material for Community-based Primary Care Project, made by ...
by Choi Gwang-seok
|
2017-04-10 11:43
라인
Daewoong releases generic of cognition-enhancing Gliatilin for export
Daewoong Pharm, which handed over the domestic selling right of Gliatilin, ...
by Lee Hye-seon
|
2017-04-07 14:53
라인
Research sheds light on thyroid cancer diagnosis controversy
Amid the continuing dispute over the over-diagnosis and overtreatment of th...
by Marian Chu
|
2017-04-07 12:41
라인
FDA allows 23andMe to sell gene tests telling risks of 10 diseases
The U.S. Food and Drug Administration Friday approved 23andMe to market the...
by Marian Chu
|
2017-04-07 11:38
라인
'My dream is to produce many other Koreas'
“Korea has changed itself from an aid-receiving country to an aid-giving on...
by Lee Hye-seon
|
2017-04-06 17:12
라인
'Help people get married before forcing them to bear babies'
A 2014 study commissioned by the National Assembly concluded that South Kor...
by Constance Williams
|
2017-04-06 13:30
라인
Lilly’s new drug marks progress for treating soft tissue sarcoma
Last year, the U.S. and European food and drug agencies granted approval to...
by Marian Chu
|
2017-04-06 10:56
라인
Biomedicine boom sweeps domestic drugmakers
A boom to develop biomedicines is sweeping the domestic pharmaceutical comp...
by Lee Hye-seon
|
2017-04-05 18:32
라인
'To leave or not to leave'
After graduating from a four-year university in Seoul, Choi Min-jung though...
by Marian Chu
|
2017-04-05 17:22
라인
LG Chem 'targets sales of $2.2-bil. in life science by 2025'
LG Chem plans to invest 1 trillion won ($890 million) into research and dev...
by Lee Hye-seon
|
2017-04-05 17:04
라인
Korea made 155 medical advances to 20 countries last year
Korea’s medical institutions had made 155 advances to 20 countries as of th...
by Marian Chu
|
2017-04-05 16:02
라인
FDA approves drug to treat Huntington’s chorea
The U.S. Food and Drug Administration approved Austedo™(deutetrabenaz...
by Constance Williams
|
2017-04-05 10:39
라인
Sanofi's Japanese encephalitis vaccine ad fuels fear
Pharmaceutical company Sanofi has come under fire for allegedly marketing i...
by Nam Doo-hyun
|
2017-04-04 17:30
라인
Ministry may introduce system to curb prices of 'blockbuster drugs'
The Ministry of Health and Welfare is considering introducing a new drug pr...
by Kwak Sung-sun
|
2017-04-04 16:34
라인
When will Korea reach diffusion points for stem cell and gene therapy technology?
Korea will likely go ahead of Japan in reaching the diffusion point of stem...
by Marian Chu
|
2017-04-04 15:54
라인
Regulation on medical service in Korea
a. Regulation by the Korean GovernmentProfit-making activities by means of ...
by Kim Sun-Wook and Kim Young-jun
|
2017-04-04 11:45
-
이전
321
322
323
324
325
326
327
328
329
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top